It was an invasive lobular carcinoma with a grade II of the Scarff–Bloom–Richardson (SBR) classification and positive hormonal receptors [estrogen receptor (ER), progesterone receptor (PR)]. The gene discussed is ESR1; the disease is invasive lobular breast carcinoma.